DA-5222-R3
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for DA-5222-R3, covering 2025-06-06 to 2025-11-17. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial Comparing Single-administration of DA-5222 and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects in Fed State [Phase 1]